The role of disposable inhalers in pulmonary drug delivery

被引:16
|
作者
de Boer, Anne H. [1 ]
Hagedoorn, Paul [1 ]
机构
[1] Univ Groningen, Dept Pharmaceut Technol & Biopharm, NL-9713 AV Groningen, Netherlands
关键词
disposable; dry powder inhaler; inhalation; nebuliser; single-dose; single-use; DRY-POWDER INHALERS; CYSTIC-FIBROSIS; COST-EFFECTIVENESS; SOLID DISPERSION; VIRUS-VACCINE; INHALATION; ANTIBIOTICS; FORMULATION; MANAGEMENT; TECHNOLOGY;
D O I
10.1517/17425247.2014.952626
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: There is increasing interest in the pulmonary route for both local and systemically acting drugs, vaccines and diagnostics and new applications may require new inhaler technology to obtain the most therapeutically and/or cost-effective administration. Some of these new applications can benefit from the use of disposable inhalers. Areas covered: Current trends in pulmonary drug delivery are presented in this review as well as the possible contribution of disposable inhalers to the improvement of pulmonary administration therein. Arguments in favour of disposable inhalers and the starting points for development of devices and their formulations are discussed. Also, a brief review of the state of the art regarding current disposable inhaler development is given. Expert opinion: Prerequisites for the use of disposable inhalers, particularly dry powder inhalers, in applications such as childhood vaccination and for preventing or stopping pandemic outbreaks of highly infectious diseases (like influenza, bird flu, SARS) are that they are simple, cheap and effective. Not only do the devices have to be simple in design, but the drug formulations should also be cheap. This may require a different approach as the formulation may not need to be adapted to improve the inhaler must be designed to enhance formulation dispersion.
引用
收藏
页码:143 / 157
页数:15
相关论文
共 50 条
  • [21] Phospholipids in pulmonary drug delivery
    Wauthoz, Nathalie
    Amighi, Karim
    EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY, 2014, 116 (09) : 1114 - 1128
  • [22] The ascent of pulmonary drug delivery
    Gonda, I
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 89 (07) : 940 - 945
  • [23] A view on the less-than-rational development of drug delivery systems - The example of dry powder inhalers
    Tucker, I. G.
    Das, S. C.
    Stewart, P. J.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2015, 30 : 310 - 317
  • [24] Albumin nanocarriers for pulmonary drug delivery: An attractive approach
    Joshi, Monica
    Nagarsenkar, Mangal
    Prabhakar, Bala
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 56
  • [25] Ciprofloxacin nanocrystals and N-acetylcysteine co-solidified powders for pulmonary drug delivery: development and in vitro and in vivo characterization
    Guan, Wenhao
    Liu, Yanchao
    Ding, Shuaijie
    Wang, Yancai
    JOURNAL OF NANOPARTICLE RESEARCH, 2022, 24 (02)
  • [26] Advances in Device and Formulation Technologies for Pulmonary Drug Delivery
    Chan, John Gar Yan
    Wong, Jennifer
    Zhou, Qi Tony
    Leung, Sharon Shui Yee
    Chan, Hak-Kim
    AAPS PHARMSCITECH, 2014, 15 (04): : 882 - 897
  • [27] Chitosan-Based Linezolid Dry Powder Inhalers: A Novel Approach for Targeted Pulmonary Delivery in Tuberculosis Treatment
    Thippeswamy, Mallamma
    Meravanige, Girish
    Shiroorkar, Predeepkumar Narayanappa
    Goudanavar, Prakash
    Naveen, Nimbagal Raghavendra
    Sreeharsha, Nagaraja
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2025, 59 (01) : s138 - s150
  • [28] The Impact of Inspiratory Flow Rate on Drug Delivery to the Lungs with Dry Powder Inhalers
    Jeffry Weers
    Andy Clark
    Pharmaceutical Research, 2017, 34 : 507 - 528
  • [29] Nano-based carriers for pulmonary drug delivery: A review on the available drug delivery applications and toxicity issues
    Siafaka, Panoraia I.
    Bulbul, Ece Ozcan
    Miliotou, Androulla N.
    Karantas, Ioannis D.
    Okur, Mehmet Evren
    Okur, Neslihan Ustundag
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 92
  • [30] Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications
    Labiris, NR
    Dolovich, MB
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (06) : 600 - 612